Changes in MDS-UPDRS after treatment with 10mg or 20mg buntanetap in patients with a PD diagnosis over 3 years compared to baseline and placebo MALVERN, Pa., July 02, 2024 (GLOBE NEWSWIRE) -- via IBN ...
In a recent study published in the journal Nature Medicine, a large, international team of researchers conducted an exploratory analysis to evaluate whether the monoclonal antibody prasinezumab, which ...
Patients with Parkinson disease treated with acupuncture-related therapies combined with conventional medication exhibited significant improvements in motor function and experiences of daily living, ...
A new artificial intelligence tool can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. While expert neurologists performed slightly better than the ...
This signals a growing focus on holistic Parkinson’s disease management. Solengepras has shown early promise in addressing Parkinson’s disease’s (PD) overlooked non-motor burden, with Phase II data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results